14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Signals

$0.0064
+0 (+0%)
At Close: Sep 17, 2019

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 64 days ( 0 % )
Last Price $0.0064 0 %
High/ Low $0.0064 - $0.0064 0%
Chg 7 Days N/A $0.0064 $0.0064
Chg 30 Days N/A $0.0064 $0.0064
Chg 12 mos -99.62 % $1.68 $0.0064
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -75.25 % Width: 145.59 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $0.0965 -100.00 % - 1,407.43 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Apr 23, 2019 - 103 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Sep 16, 2019 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,... SGYP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT